Insulet (PODD) Non-Current Assets (2010 - 2026)
Insulet (PODD) reported Non-Current Assets of $1.3 billion for Q1 2026, up 7.47% on a YoY basis from $1.2 billion in Q1 2025, and little changed quarter-over-quarter from $1.3 billion in Q4 2025.
Insulet (PODD) Non-Current Assets (2010 - 2026) Analysis & Trends
Insulet has reported Non-Current Assets for 17 years, with the latest figure at $1.3 billion in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets rose 7.47% year-over-year to $1.3 billion; the trailing twelve-month figure through Mar 2026 stood at $4.9 billion (up 4.93% YoY), and the FY2025 full-year result was $1.3 billion, up 6.69% from the prior year.
- Non-Current Assets for Q1 2026 stood at $1.3 billion, roughly flat from $1.3 billion in the prior quarter.
- The five-year high for Non-Current Assets was $1.3 billion in Q1 2026, with the low at $783.8 million in Q1 2022.
- Historically, Non-Current Assets has averaged $1.1 billion across 5 years, with a median of $1.0 billion in 2024.
- Annual changes were most pronounced in 2022 — Non-Current Assets soared 30.33% — and 2025, when it gained 0.46%.
- Insulet's Non-Current Assets stood at $937.1 million in 2022, then rose by 7.28% to $1.0 billion in 2023, then gained by 19.01% to $1.2 billion in 2024, then grew by 6.69% to $1.3 billion in 2025, then climbed by 0.1% to $1.3 billion in 2026.
- The last three Non-Current Assets figures came in at $1.3 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 67.41 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.47 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.30 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 8.34 Bn |
| 10 | Insulet | 10.20 Bn | 9.72 Bn | 529.10 Mn | 1.28 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.28 Bn |
| Dec 31, 2025 | 1.28 Bn |
| Sep 30, 2025 | 1.17 Bn |
| Jun 30, 2025 | 1.19 Bn |
| Mar 31, 2025 | 1.19 Bn |
| Dec 31, 2024 | 1.20 Bn |
| Sep 30, 2024 | 1.16 Bn |
| Jun 30, 2024 | 1.13 Bn |
| Mar 31, 2024 | 1.01 Bn |
| Dec 31, 2023 | 1.01 Bn |
| Sep 30, 2023 | 996.60 Mn |
| Jun 30, 2023 | 964.30 Mn |
| Mar 31, 2023 | 959.10 Mn |
| Dec 31, 2022 | 937.10 Mn |
| Sep 30, 2022 | 837.10 Mn |
| Jun 30, 2022 | 804.60 Mn |
| Mar 31, 2022 | 783.80 Mn |
| Dec 31, 2021 | 719.00 Mn |
| Sep 30, 2021 | 692.00 Mn |
| Jun 30, 2021 | 670.80 Mn |